Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1859 USD | +3.28% | +10.00% | -57.78% |
Business Summary
Number of employees: 77
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +9.58% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +9.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Wolf
CEO | Chief Executive Officer | 60 | 08-06-09 |
Director of Finance/CFO | 56 | 19-09-24 | |
David Waldman
IRC | Investor Relations Contact | - | - |
George Peoples
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
BRD | Director/Board Member | 70 | 16-04-25 |
Jeff Wolf
CEO | Chief Executive Officer | 60 | 08-06-09 |
Edward Smith
BRD | Director/Board Member | 48 | 08-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 09-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,031,964 | 34,120,048 ( 94.69 %) | 0 | 94.69 % |
Company contact information
Scorpius Holdings, Inc.
627 Davis Drive Suite 300
27560, Morrisville
+919 240 7133
http://ww.ir.scorpiusbiologics.comSector
1st Jan change | Capi. | |
---|---|---|
-57.78% | 6.7M | |
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- SCPX Stock
- Company Scorpius Holdings, Inc.